William Plovanic
Stock Analyst at Canaccord Genuity
(3.00)
# 1,292
Out of 5,182 analysts
184
Total ratings
38.79%
Success rate
1.51%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Hold | $87 → $85 | $83.46 | +1.85% | 31 | Apr 24, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $109 → $71 | $59.95 | +18.43% | 16 | Apr 23, 2026 | |
| CVRX CVRx, Inc. | Maintains: Buy | $10 | $7.65 | +30.72% | 11 | Apr 14, 2026 | |
| STIM Neuronetics | Maintains: Buy | $7 → $3 | $1.69 | +77.51% | 5 | Mar 19, 2026 | |
| HTFL HeartFlow | Maintains: Buy | $40 → $43 | $31.73 | +35.52% | 5 | Mar 19, 2026 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $7 | $4.50 | +55.56% | 7 | Mar 9, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $212 → $198 | $125.96 | +57.19% | 14 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $450 → $435 | $188.31 | +131.00% | 8 | Feb 19, 2026 | |
| ATRC AtriCure | Maintains: Buy | $64 → $53 | $29.04 | +82.51% | 13 | Feb 18, 2026 | |
| DXCM DexCom | Maintains: Buy | $99 → $95 | $61.41 | +54.70% | 10 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $48 | $37.03 | +29.62% | 5 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $35 | $19.82 | +76.59% | 7 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $147 → $148 | $108.12 | +36.88% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $30 | $21.14 | +41.91% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $11.09 | +62.31% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $93.70 | -3.95% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $92.59 | +9.08% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $10.01 | +49.85% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $327.98 | -13.41% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $10.36 | +141.31% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.28 | +837.50% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $67.43 | +3.81% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $26.68 | +79.91% | 5 | Aug 3, 2023 |
Edwards Lifesciences
Apr 24, 2026
Maintains: Hold
Price Target: $87 → $85
Current: $83.46
Upside: +1.85%
Boston Scientific
Apr 23, 2026
Maintains: Buy
Price Target: $109 → $71
Current: $59.95
Upside: +18.43%
CVRx, Inc.
Apr 14, 2026
Maintains: Buy
Price Target: $10
Current: $7.65
Upside: +30.72%
Neuronetics
Mar 19, 2026
Maintains: Buy
Price Target: $7 → $3
Current: $1.69
Upside: +77.51%
HeartFlow
Mar 19, 2026
Maintains: Buy
Price Target: $40 → $43
Current: $31.73
Upside: +35.52%
TriSalus Life Sciences
Mar 9, 2026
Maintains: Buy
Price Target: $7
Current: $4.50
Upside: +55.56%
iRhythm Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $212 → $198
Current: $125.96
Upside: +57.19%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $450 → $435
Current: $188.31
Upside: +131.00%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $64 → $53
Current: $29.04
Upside: +82.51%
DexCom
Feb 13, 2026
Maintains: Buy
Price Target: $99 → $95
Current: $61.41
Upside: +54.70%
Feb 13, 2026
Maintains: Buy
Price Target: $51 → $48
Current: $37.03
Upside: +29.62%
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $19.82
Upside: +76.59%
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $108.12
Upside: +36.88%
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $21.14
Upside: +41.91%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $11.09
Upside: +62.31%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $93.70
Upside: -3.95%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $92.59
Upside: +9.08%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $10.01
Upside: +49.85%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $327.98
Upside: -13.41%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $10.36
Upside: +141.31%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.28
Upside: +837.50%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $67.43
Upside: +3.81%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $26.68
Upside: +79.91%